A Prospective, Non-interventional Multi-center Observational Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis in Routine Practice
Phase of Trial: Phase IV
Latest Information Update: 07 Mar 2018
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Roche
- 28 Feb 2018 Status changed from recruiting to completed.
- 01 Jul 2016 Planned End Date changed from 1 Jun 2018 to 1 Jun 2017.
- 01 Jul 2016 Planned primary completion date changed from 1 Jun 2018 to 1 Jun 2017.